Announced on October 9, the decision to issue a CRL is based on the FDA's belief the clinical meaningfulness of patisiran’s treatment effects for the cardiomyopathy of ATTR amyloidosis had not been established.
Strange Advance and Spoons concert in New Westminster BC newwestrecord.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newwestrecord.ca Daily Mail and Mail on Sunday newspapers.